Substance induced disorders: Moving towards DSM-V and ICD-11;Substanz-bezogene störungen: Auf dem weg zu ICD-11 und DSM-V

Fortschritte der Neurologie Psychiatrie

Volumn 74, Issue 11, 2006, Pages 634-642

  Schmidt, Lutz G ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COMORBIDITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE CLASSIFICATION; HEALTH CARE ORGANIZATION; HUMAN; MENTAL DISEASE; REVIEW; SUBSTANCE ABUSE;

ALCOHOLISM; COMORBIDITY; DIAGNOSIS, DIFFERENTIAL; DIAGNOSIS, DUAL (PSYCHIATRY); DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; MENTAL DISORDERS; SUBSTANCE-RELATED DISORDERS; TERMINOLOGY;

EID: 33845394337     PISSN: 07204299     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-919079     Document Type: Review

References (96)

1. APA: Diagnostische Kriterien des Diagnostischen und Statistischen Manuals Psychischer Störungen DSM IV. Göttingen: Hogrefe, 1998
2. Weltgesundheitsorganisation. Internationale Klassifikation psychischer Störungen. Klinisch-diagnostische Leitlinien. 4. Auflage. Bern: Huber, 2000
3. Kupfer DJ, First MB, Regier DA. A research agenda for DSM-V. Washington D.C.: American Psychiatric Publishing Inc, 2002
4. Robins LN. Using survey results to improve the validity of the standard psychiatric nomenclature. Arch Gen Psychiat 2004; 61: 188-1194
5. Self D. Drug dependence and addiction: neural substrates. Am J Psychiat 2004; 161: 223-223
6. Edwards G, Gross M. Alcohol dependence: provisional description of a clinical syndrome. Br Med J 1976; 1: 1058-1061
7. Feingold A, Rounsaville B. Construct validity of the dependence syndrome as measured by DSM-IV for different psychoactive substances. Addiction 1995; 90: 1661-1669
8. Lessov CN, Martin NG, Statham DJ, Todorov AA, Slutske WS, Bucholz KK, Heath AC, Madden PAF. Defining nicotine dependence for genetic research: evidence from Australian twins. Psychol Med 2004; 34: 865-879
9. Wu LT, Pilowsky DJ, Schlenger WE. Inhalant abuse and dependence among adolescents in the United States. J Am Acad Child Adolesc Psychiat 2004; 43: 1206-1214
10. Tyrer P. Risks of dependence on benzodiazepine drugs: the importance of patient selection. Br Med J 1989; 102: 104-104
11. Copeland J, Peters R, Dillon P. Anabolic-androgenic steroid use disorders among a sample of Australian competitive and recreational users. Drug Alc Depend 2000; 60: 91-96
12. Lejoyeux M, McLoughlin M, Ades J. Epidemiology of behavioural dependence: literature review and results of original studies. Eur Psychiat 2000; 15: 129-134
13. Edwards G, Arif A, Hadgson R. Nomenclature and classification of drug-and alcohol-related problems: a WHO Memorandum. Bull World Health Organ 1981; 59: 225-242
14. World Health Organisation (WHO). Regional Office for Europe: Alcohol and health - implications for Public Health Policy. Norway: Report of a WHO Working Group, 1995
15. British Medical Association (BMA). Alcohol. Guidelines on sensible drinking. London: British Medical Association, 1995
16. Sartorius N, Kaelber CT, Cooper JE, Roper NT, Rae DS, Gulbinat W, Ustun TB, Regier DA. Progress towards achieving a common language in Psychiatry. Results from the field trial of the clinical guidelines accompanying the WHO classification of mental and behavioral disorders in ICD-10. Arch Gen Psychiat 1993; 50: 115-124
17. Edwards G. The alcohol dependence syndrome: a concept as stimulus to enquiry. Br J Addiction 1986; 81: 171-183
18. Schuckit MA, Hesselbrock V, Tipp J, Anthenelli R, Bucholz K, Radziminski S. A comparison of DSM-III-R, DSM-IV and ICD-10 substance use disorders diagnoses in 1992 men and women subjects in the COGA study. Addiction 1994; 89: 1629-1638
19. Ustun B, Compton W, Mager D, Babor T, Baiyewu O, Chatterji S, Cottler L, Gogus A, Mavreas V, Peters L, Pull C, Saunders J, Smeets R, Stipec MR, Vrasti R, Hasin D, Room R, Brink W van den, Regier D, Blaine J, Grant BF, Sartorius N. WHO study on the reliability and validity of the alcohol and drug use disorder instruments: overview of methods and results. Drug Alc Depend 1997; 47: 161-169
20. Pull CB, Saunders J, Mavreas V et al. Concordance between ICD-10 alcohol and drug use disorder criteria and diagnoses as measured by the AUDADIS-ADR, CIDI and SCAN: results of a cross national study. Drug Alc Depend 1997; 47: 207-216
21. Hasin D. Classification of alcohol use disorders. Alcohol Res & Health 2003; 27: 5-17
22. Schmidt LG, Dufeu P, Rommelspacher H. Diagnostik der Alkoholabhä ngigkeit. Nervenarzt 1993; 64: 36-44
23. Grant BF. ICD-10 and proposed DSM-IV harmful use of alcohol/alcohol abuse and dependence, United States 1988: a nosological comparison. Alc Clin Exp Res 1993; 17: 1093-1101
24. Hasin DS, Grant B. Nosological comparisons of DSM-III-R and DSM-IV alcohol abuse and dependence in a clinical facility: comparison with the 1988 national health Interview survey results. Alc Clin Exp Res 1994; 18: 272-279
25. Martin CS, Kaszynski NA, Maisto SA, Bukstein OM, Moss HB. Patterns of DSM-IV alcohol abuse and dependence symptoms in adolescent drinkers. J Stud Alc 1995; 56: 672-680
26. Nelson CB, Wittchen HU. DSM-IV alcohol disorders in a general population sample of adolescents and young adults. Addiction 1998; 93: 1065-1067
27. Heath AC, Bucholz KK, Slutske WS et al. The assessment of alcoholism in surveys of the general community: what are we measuring? Some insights from the Australian twin panel interview survey. International Review of Psychiatry 1994; 6: 295-307
28. Fulkerson JA, Harrison PA, Beebe TJ. DSM-IV substance abuse and dependence: are there really two dimensions of substance disorders in adolescents? Addiction 1995; 94: 495-506
29. Nelson CB, Rehm J, Ustun TB, Grant B, Chatterji S. Factor structure for DSM-IV substance disorders criteria endorsed by alcohol, cannabis, cocaine and opiate users: results from the WHO reliability and validity study. Addiction 1999; 94: 843-855
30. Teesson M, Lynskey M, Manor B, Baillie A. The structure of cannabis dependence in the community. Drug Alc Depend 2002; 68: 266-262
31. Harford TC, Muthen B. The dimensionality of alcohol abuse and dependence: a multivariate analysis of DSM-IV symptom items in the National Longitudinal Survey of Youth. J Stud Alc 2001; 62: 150-157
32. Schuckit MA, Smith TL, Danko GP, Bucholz KK, Reich T, Bierut L. Five-year clinical course associated with DSM-IV alcohol abuse or dependence in a large group of men and women. Am J Psychiat 2001; 158: 1084-1090
33. Schuckit MA, Dank GP, Smith TL, Hesselbrock V, Kramer J, Bucholz K. A 5-year prospective evaluation of the DSM-IV alcohol dependence with and without a physiological component. Alc Clin ExpRes 2003; 27: 818-825
34. DeBellis MD. Developmental traumatology: a contributory mechanism for alcohol and substance use disorders. Psychoneuroendocrinol 2002; 27: 155-170
35. Hasin D, Rossem R van, McCloud S, Endicott J. Alcohol dependence and abuse diagnoses: validity in community sample heavy drinkers. Alc Clin Exp Res 1997; 21: 213-219
36. Hoffmann NG, Hoffmann TD. Construct validity for alcohol dependence as indicated by the SUDDS-IV. Substance Use and Misuse 2003; 38: 293-306
37. Hasin D, Paykin A. Alcohol dependence and abuse diagnoses: concurrent validity in a national representative sample. Alc Clin Exp Res 1999; 23: 144-150
38. Hasin DS, Grant BF. Major depression in 6,050 former drinkers: association with past alcohol dependence. Arch Gen Psychiat 2002; 59: 794-800
39. Schuckit MA, Smith TL, Daeppen JB, Eng M, Li TK, Hesselbrock VM, Nurnberger Jr JI, Bucholz KK. Clinical relevance of the distinction between alcohol dependence with and without a physiological component. Am J Psychiat 1998; 155: 733-740
40. Hasin D, Paykin A, Meydan J, Grant BF. Withdrawal and tolerance in DSM-IV alcohol dependence. J Stud Alc 2000; 63: 431-438
41. Hasin D, Grant BF, Endicott J. The natural history of alcohol abuse: implications for the definitions of alcohol use disorders. Am J Psychiat 1990; 147: 1537-1541
42. Langenbucher JW, Chung T. Onset and staging of DSM-IV alcohol dependence using mean age and survivalized methods. J Abn Psychol 1995; 104: 346-354
43. Grant BF, Stinson FS, Harford TC. Age at onset of alcohol use, and DSM-IV alcohol and substance abuse and dependence: a 12-year follow up. J Subst Abuse 2001; 13: 493-504
44. Ridenour TA, Cottler LB, Compton WM, Spitznagel WM, Cunningham-Williams RM. Is there a progression from abuse disorders to dependence disorders? Addiction 2003; 98: 635-644
45. Schuckit MA, Smith TL, Danko GP, Kramer J, Godinez J, Bucholz KK, Nurnberger JI, Hesselbrock V. Prospective evaluation of the four DSM-IV criteria for alcohol abuse in a large population. Am J Psychiat 2005; 162: 350-360
46. Eng MY, Schuckit MS, Smith TL. A five-year prospective study of diagnostic orphans for alcohol use disorders. J Stud Alc2003; 64: 227-234
47. Degenhardt L, Lynskey M, Coffey C, Patton G. "Diagnostic orphans" among young adult cannabis users: persons who report dependence symptoms but do not meet diagnostic criteria. Drug Alc Depend 2002; 67: 205-212
48. Rounsaville BJ, Bryant K, Babor TF et al. Cross-system agreement for substance use disorders: DSM-IIIR, DSM-IV and ICD-10. Addiction 1993; 88: 337-348
49. Bucholz KK, Cadoret R, Cloninger CR, Dinwiddie SH, Hesselbrock VM, Nurnberger Jr JI, Reich T, Schmidt I, Schuckit MA. A new, semi-structured psychiatric inerview for use in genetic linkage studies: a report on the reliability of the SSAGA. J Stud Alc 1994; 55: 149-158
50. Cottler LB, Grant BF, Blaine J et al. Concordance of DSM-IV alcohol and drug use disorder criteria and diagnoses as measured by AUDADIS-ADR, CIDI and SCAN. Drug Alc Depend 1997; 47: 195-205
51. Chatterji S, Saunders J, Vrasti R et al. Reliability of the alcohol and drug modules of the Alcohol Use Disorders and Associated Disabilities Interview Schedule-Alcohol/Drug Revised (AUDADIS-ADR): an international comparison. Drug Alc Depend 1997; 47: 171-185
52. Rounsaville BJ. Experience with ICD-10/DSM-IV substance use disorders. Psychopathology 2002; 35: 82-88
53. Kramer HC, Noda A, O'Hara R. Categorical vs. dimensional approaches to diagnosis: methodological challenger. J Psychiat Res 2004; 38: 17-25
54. Os J van, Gilvary C, Bale R, Horn E van, Tattan T, White I, Murray R. A comparison of the utility of dimensional and categorical representations of psychosis. UK700 Group. Psychol Med 1999; 29: 595-606
55. Peralta V, Cuesta MJ. Clinical models of schizophrenia: a critical approach to competing conceptions. Psychopathology 2000; 33: 252-258
56. Peralta V, Cuesta MJ, Giraldo C, Cardenas A, Gonzalez F. Classifying psychotic disorders: issues regarding categorical vs. dimensional approaches and time frame to assess symptoms. Eur Arch Psychiat Clin Neurosci 2002; 252: 12-18
57. Wanberg KW, Horn JL, Foster FM. A differential assessment model for alcoholism. The scales of the Alcohol Use Inventory. J Stud Alc 1977; 38: 512-543
58. Tarter RE, Moss HB, Arria A, Mezzich AC, Vanyukov MM. The psychiatric diagnosis of alcoholism: critique and proposed reformation. Alc Clin Exp Res 1992; 16: 106-116
59. Mayfield D, McLeod G, Hall P. The CAGE questionnaire: validation of a new alcoholism screening instrument. Am J Psychiat 1974; 131: 1121-1123
60. Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption. II. Addiction 1993; 88: 791-804
61. Skinner HA, Allen BA. Alcohol dependence syndrome: measurement and validation. J Abn Psychol 1982; 91: 199-209
62. Mc Lellan AT, Luborsky L, Woody GE. An improved diagnostic evaluation instrument for substance abuse patients: the Addiction Severity Index. J Nerv Ment Dis 1980; 168: 26-33
63. Cottler LB, Keating SK. Operationalization of drug and alcohol dependence criteria by means of a structured interview. Recent Develop Alc 1990; 8: 69-83
64. Spitzer RL, Williams J, Kroenke K. Research Quick Guide to Patient Health Questionnaire (PHQ) and Brief PHQ. New York: New York State Psychiatric Institute, 1999
65. Regier DA, Kaelber CT, Rae DS, Farmer ME, Knauper B, Kessler RC, Norquist GS. Limitations of diagnostic criteria and assessment instruments for mental disorders. Implications for research and policy. Arch Gen Psychiatry 1998; 55: 109-115
66. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK. Comorbidity of mental disorders with alcohol and other drugs of abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990; 264: 2511-2518
67. Kessler RC, Crum RM, Warner LA, Nelson CB, Schulenberg J, Anthony JC. Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch Gen Psychiat 1997; 54: 313-321
68. Shiffman S, Waters AJ, Pomerlau CS, Bolt DM, Brigham J, Swan GE. A multidimensional measure of nicotine dependence. Nicotine and Tobacco Research 2003; 5: 655-664
69. Budney AJ, Hughes JR, Moore BA, Vandrey R. Review of the validity and significance of cannabis withdrawal syndrome. Am J Psychiatry 2004; 161: 1967-1977
70. Maser JD, Patterson P. Spectrum and nosology: implications for DSM-V. Psychiatric Clinics of North America 2002; 25: 855-885
71. O'Brian CP, Charney DS. Priority actions to improve the care of persons with co-occurring substance abuse and other mental disorders: a call to action. Biol Psychiat 2004; 56: 703-713
72. Grant BF, Stinson FS, Dawson DA, Chou SP, Dufour MC, Compton W, Pickering RP, Kaplan K. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the national Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiat 2004; 61: 807-816
73. Schuckit MA, Tipp TE, Bucholz KK, Nurnberger Jr JI, Hesselbrock VM, Crowe RR, Kramer J. The life-time rates of three major mood disorders and four major anxiety disorders in alcoholics and controls. Addiction 1997; 92: 1289-1304
74. Hambrecht M, Häfner H. Substance abuse and the onset of schizophrenia. Biol Psychiat 1996; 40: 1155-1163
75. Zammit S, Allebeck P, Andreasson S, Lundberg I, Lewis G. Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. Br Med J 2002; 325: 1199-1201
76. Zammit S, Allebeck P, Dalman C, Lundberg I, Hemmingsson T, Lewis G. Investigating the association between cigarette smoking and schizophrenia in a cohort study. Am J Psychiat 2003; 160: 2216-2221
77. Bolanos CA, Barrot M, Berton O, Wallace-Black D, Nestler EJ. Methylphenidate treatment during pre- and periadolescence alters behavioural respsonses to emotional stimuli at adulthood. Biol Psychiat 2003; 54: 1317-1329
78. Volkow ND. The reality of comorbidity: depression and drug abuse. Biol Psychiat 2004; 56: 714-717
79. Caton CLM, Drake RE, Hasin HS, Dominguez B, Shrout PE, Samet S, Schanzer WB. Differences between early-phase primary psychotic disorders with concurrent substance use and substance-induced psychoses. Arch Gen Psychiat 2005; 62: 137-145
80. Hasin DS, Trautman KD, Miele GM, Sarnet S, Smith M, Endicott J. Psychiatric research interview for substance and mental disorders (PRISM): reliability for substance abusers. Am J Psychiat 1996; 153: 1195-1201
81. Grant BF, Harford TC, Dawson DA, Chou PS, Pickering RP. The Alcohol Use Disorder and Associated Disabilities Interview schedule (AUDA-DIS): reliability of alcohol and drug modules in a general population sample. Drug Alcohol Depend 1995; 39: 37-44
82. Bucholz KK, Cadoret R, Cloninger CR, Dinwiddie SH, Hesselbrock VM, Nurnberger Jr JI, Reich T, Schmidt I, Schuckit MA. A new, semi-structured psychiatric interview for use in genetic linkage studies: a report on the reliability of the SSAGA. J Stud Alcohol 1994; 55: 149-158
83. Nunes EV, Levin FR. Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis. JAMA 2004; 291: 1887-1896
84. Babor TF, Hoffman M, Del Boca FK, Hesselbrock V, Meyer RE, Dolinsky ZS, Rounsaville B. Types of alcoholics, I: evidence for an empirically derived typology based on indicators of vulnerability and severity. Arch Gen Psychiat 1992; 49: 599-608
85. Windle M, Scheidt DM. Alcoholic subtypes: are two sufficient? Addiction 2004; 99: 1508-1519
86. Krueger RF. The structure of common mental disorders. Arch Gen Psychiat 1999; 56: 921-926
87. Li TK, Hewitt BG, Grant BF. Alcohol use disorders and mood disorders: a National Institute on Alcohol Abuse and Alcoholism perspective. Biol Psychiat 2004; 56: 718-720
88. Volkow ND, Wang GJ, Fowler JS, Logan J, Hitzemann R, Ding YS, Pappas N, Shea C, Piscani K. Decreases in dopamine receptors but not in dopamine transporters in alcoholics. Alcohol Clin Exp Res 1996; 20: 1594-1598
89. Heinz A, Siessmeier T, Wrase J, Hermann D, Klein S, Grusser SM, Flor H, Braus DF, Buchholz HG, Grunder G, Schreckenberger M, Smolka MN, Rosch F, Mann K, Bartenstein P. Correlation between dopamine D(2) receptors in the ventral striatum and central processing of alcohol cues and craving. Am J Psychiatry 2004; 161: 1783-1789
90. Nestler AJ, Agjanian GK. Molecular and cellular basis of addiction. Science 1997; 278: 58-63
91. Rangaswamy M, Porjesz B, Chorlian DB, Wang K, Jones KA, Bauer LO, Rohrbaugh J, O'Connor SJ, Kuperman S, Reich T, Begleiter H. Beta power in the EEG of alcoholics. Biol Psychiatry 2002; 52: 831-842
92. Edenberg HJ, Dick DM, Xuei X, Tian H, Almasy L, Bauer LO, Crowe RR, Goate A, Hesselbrock V, Jones K, Kwon J, Li TK, Nurnberger Jr JI, O''Connor SJ, Reich T, Rice J, Schuckit MA, Porjesz B, Foroud T, Begleiter H. Variations in GABA2, encoding the alpha 2 subunit of the GABA(A) receptor are associated with alcohol dependence and with brain oscillations. Am J Hum Genet 2004; 74: 705-714
93. Higuchi S, Matsushita S, Imazeki H, Kinoshita T, Takagi S, Kono H. Aldehyde dehydrogenase genotypes in Japanese alcoholics. Lancet 1994; 343: 741-742
94. Petry NM. Substance abuse, pathological gambling, and impulsiveness. Drug Alcohol Depend 2001; 63: 29-38
95. Reuter J, Rädler T, Rose M, Hand I, Glaser J, Buchel C. Pathological gambling is linked to reduced activation of the mesolimbic reward system. Nat Neurosci 2005; 8: 147-148
96. Kessler RC, Merikangas KR, Berglund P, Eaton WW, Koretz DS, Walters EE. Mild disorders should not be eliminated from the DSM-V. Arch Gen Psychiat 2003; 60: 1117-1122